MedDataX Logo

Surgical Versus Medical Treatment of Acromegaly

NCT ID: NCT01000090

Last Updated: 2015-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

63 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-10-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone).

Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acromegaly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acromegaly patients, somatostain analogues

No interventions assigned to this group

Acromegaly patients, surgery

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acromegaly diagnosis
* treated with Somatostatin analogues or surgery
* in treatment control

Exclusion Criteria

* treatment with GH-antagonist
* never treated
* not in treatment control
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kristine Z Rubeck, stud. med.

Role: STUDY_DIRECTOR

Medical department M, Århus University Hospital

Jens Otto L Jørgensen, MD

Role: PRINCIPAL_INVESTIGATOR

Medical department M, Århus University Hospital

Michael Madsen, MD

Role: STUDY_DIRECTOR

Medical department M, Århus University Hospital

Sanne Fisker, MD

Role: STUDY_DIRECTOR

Medical department M, Århus University Hospital

Caroline Adreasen, MD

Role: STUDY_DIRECTOR

Medical department M, Århus University Hospital

Jan Frystyk, MD

Role: STUDY_DIRECTOR

Medical department M, Århus University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Århus University Hospital, Medical department M

Aarhus, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

kzr200809

Identifier Type: -

Identifier Source: org_study_id